Implementation of the radiotheranostic concept in human PCa starts with diagnostic imaging to identify GRPR-positive lesions, which are amenable to treatment with a therapeutic anti-GRPR counterpart [15,16,17]. Here, GRPR is linked to posterior cortical atrophy.